DOBUTAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dobutamine Hydrochloride, and what generic alternatives are available?
Dobutamine Hydrochloride is a drug marketed by Baxter Hlthcare, Dr Reddys, Hainan Poly, Hikma, Hospira, Luitpold, Teligent, Teva Parenteral, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.
The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride
A generic version of DOBUTAMINE HYDROCHLORIDE was approved as dobutamine hydrochloride by HOSPIRA on November 29th, 1993.
Summary for DOBUTAMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 15 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 102 |
Clinical Trials: | 115 |
Patent Applications: | 740 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in DOBUTAMINE HYDROCHLORIDE? | DOBUTAMINE HYDROCHLORIDE excipients list |
DailyMed Link: | DOBUTAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wuhan Union Hospital, China | Phase 2/Phase 3 |
Ain Shams University | Phase 2/Phase 3 |
University of Chicago | Early Phase 1 |
Pharmacology for DOBUTAMINE HYDROCHLORIDE
Drug Class | beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta-Agonists |
Medical Subject Heading (MeSH) Categories for DOBUTAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DOBUTAMINE HYDROCHLORIDE
US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074381-001 | Sep 26, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dobutamine hydrochloride | INJECTABLE;INJECTION | 020255-004 | Oct 19, 1993 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hospira | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074292-001 | Feb 16, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074277-001 | Oct 31, 1994 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |